Clara V Alvarez (Clara V Álvarez)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Venues

Nature communications

Oncogene

Cancers

Cells

University of Santiago de Compostela

University of Santiago de Compostela (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Santiago de Compostela

Spain

PI, Acred. Professor :: Neoplasia & Endocrine Differentiation, Center of Investigation in Molecular Medicine and Chronic Disease (CIMUS)

Universidade de Santiago de Compostela

Spain

Associate Professor :: Physiology

Universidade de Vigo

Spain

Assistant Professor

Universidade de Santiago de Compostela

Spain

Associate investigator_Contrato Reincorporación :: Physiology

Education History

University of Santiago de Compostela

Spain

PHD :: Physiology_Endocrinology

Publications

Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
Author Correction: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
Author Correction: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
Author Correction: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
Author Correction: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Joana S Rodrigues, Miguel Chenlo, Susana Belén Bravo, Sihara Perez-Romero, Maria Suarez-Fariña, Tomás Sobrino, Rebeca Sanz-Pamplona, Román González-Prieto, Manuel Narciso Blanco Freire, Ruben Nogueiras, Miguel López, Laura Fugazzola, José Manuel Cameselle-Teijeiro, Clara V Alvarez
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nature communications 15 (1) (2024)
Angela R Garcia-Rendueles, Miguel Chenlo, Fernando Oroz-Gonjar, Antonia Solomou, Anisha Mistry, Sayka Barry, Carles Gaston-Massuet, Montserrat Garcia-Lavandeira, Sihara Perez-Romero, Maria Suarez-Fariña, Alberto Pradilla-Dieste, Carlos Dieguez, Patrick Mehlen, Marta Korbonits, Clara V Alvarez
Correction: RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas. Oncogene (2023)
Denis Horgan, Dagmar Führer-Sakel, Paula Soares, Clara V Alvarez, Laura Fugazzola, Romana T Netea-Maier, Barbara Jarzab, Marta Kozaric, Beate Bartes, James Schuster-Bruce, Luigino Dal Maso, Martin Schlumberger, Furio Pacini
Tackling Thyroid Cancer in Europe-The Challenges and Opportunities. Healthcare (Basel, Switzerland) 10 (9) (2022)
Diego Caicedo, Clara V Alvarez, Sihara Perez-Romero, Jesús Devesa
The Inflammatory Pattern of Chronic Limb-Threatening Ischemia in Muscles: The TNF-α Hypothesis. Biomedicines 10 (2) (2022)
Javier Lugilde, Sabela Casado, Daniel Beiroa, Juan Cuñarro, Montserrat Garcia-Lavandeira, Clara V Alvarez, Ruben Nogueiras, Carlos Diéguez, Sulay Tovar
LEAP-2 Counteracts Ghrelin-Induced Food Intake in a Nutrient, Growth Hormone and Age Independent Manner. Cells 11 (3) (2022)
Angela R Garcia-Rendueles, Miguel Chenlo, Fernando Oroz-Gonjar, Antonia Solomou, Anisha Mistry, Sayka Barry, Carles Gaston-Massuet, Montserrat Garcia-Lavandeira, Sihara Perez-Romero, Maria Suarez-Fariña, Alberto Pradilla-Dieste, Carlos Dieguez, Patrick Mehlen, Marta Korbonits, Clara V Alvarez
RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas. Oncogene 40 (45) (2021)
Joanne Heade, Fiona McCartney, Miguel Chenlo, Olga Moreno Marro, Maja Severic, Robert Kent, Sinead B Bleiel, Clara V Alvarez, Brendan T Griffin, David J Brayden
Synthesis and In Vivo Evaluation of Insulin-Loaded Whey Beads as an Oral Peptide Delivery System. Pharmaceutics 13 (5) (2021)
Iacopo Gesmundo, Giuseppina Granato, Antonio C Fuentes-Fayos, Clara V Alvarez, Carlos Dieguez, Maria Chiara Zatelli, Noemi Congiusta, Dana Banfi, Nunzia Prencipe, Sheila Leone, Luigi Brunetti, Justo P. Castaño, Raúl M Luque, Renzhi Cai, Wei Sha, Ezio Ghigo, Andrew V Schally, Riccarda Granata
Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic Signaling. Cancers 13 (16) (2021)
Diego Caicedo, Pablo Devesa, Clara V Alvarez, Jesús Devesa
Why Should Growth Hormone (GH) Be Considered a Promising Therapeutic Agent for Arteriogenesis? Insights from the GHAS Trial. Cells 9 (4) (2020)
Miguel Chenlo, Elvin Aliyev, Joana S Rodrigues, Paula Vieiro-Balo, Manuel N Blanco Freire, José Manuel Cameselle-Teijeiro, Clara V Alvarez
Sequential Colocalization of ERa, PR, and AR Hormone Receptors Using Confocal Microscopy Enables New Insights into Normal Breast and Prostate Tissue and Cancers. Cancers 12 (12) (2020)

Clara V Alvarez.css-eqlu8i{font-size:small;padding-left:4px;} (Clara V Álvarez)

Publication Activity (10 Years)

Top Topics

Top Venues

Clara V Alvarez (Clara V Álvarez)